Reddit Posts
Any advice on what to YOLO on this week?
How I am Positioning myself in the Markets going into 2024
Does FSR really look like a buy or YOLO?
What's a better long term buy now. BMY vs. PFE?
Seeking suggestions on companies to swap DIS, PFE and BMY with in year end tax loss harvesting
$RNXT $1.00 +25.63% #Cancer #Treatment #Research
$PFE Pfizer down 8% since Cramer’s buy call 12 days ago
What stocks are under additional pressure in December due to tax loss harvesting?
Cramer shuffling papers this morning over $PFE
@PFE Pfeizer 5.5% Yield with January Effect and Weight loss pill testing
Why wouldn't you invest a large amount of money into Pfizer right now and ride it out for a few years?
Long time investment, estimated rocketing by 2025 [CYBN]
7 Diabetes and Weight Loss Drug Stocks With Big Potential
$RGBP Must read mRNA #FDA in play!
Down 11% on taxable account. Planning on buying a house in the next 2.5-3 years. Should I sell or change strategies?
I told you so 5 months ago - NO RECESSION NO PIVOT
BNOX - Bionomics Shares In Rally Mode As Investors Take Interest Ahead Of Planned Phase III Trial To Treat PTSD And SAD ($BNOX)
$NRXS IBS treatment with less side effects than their competitors
CDC: New Variant BA.2.86 More Capable of Causing Infection In Those Previously Vaccinated or Infected
Bull Case Through EOY : Pfizer ($PFE)
WSJ: Pfizer’s Covid Boost Crashes to Earth. "Shares are down 31% YTD, a loss of more than $88 billion in market capitalization"
Post-COVID Era Plays (Lessons from $PFE earnings)
what does it mean if a company has over 100% institutional ownership
Bull Thesis for Dr Reddy’s Laboratories (NYSE: RDY)
$SGEN spread at 15% now looking like steal of a Merger play
What to do for Pfizer's Earnings tomorrow morning
Why I'm not playing LOGI Earnings Tonight
Stocks could soar in the 'return to work from home' play as BNTX vaccine shown to be 4% effective vs circulating XBB Variant in new study
Stocks Set To Soar As Bivalent Vaccine Found 4% Effective Vs XBB Covid Variant
Johnson & Johnson Earnings Are Here: Should You Buy?
Tiziana Life Sciences $TLSA is Bracing for an Explosive 2023
The Catalysts Behind Tiziana Life Sciences' (NASDAQ: TLSA) 70%
Mirati | Investors are to Fight Losses from $MRTX downfall.
Pfizer, Astellas avoid forced price reduction for cancer drug Xtandi (NYSE:PFE)
Pfizer CEO pockets $33M for 2022 after 36% pay hike (NYSE:PFE)
AbbVie, Gilead, Seagen fined for raising prices faster than inflation (NYSE:PFE)
Pfizer faces resistance in plans to modify EU COVID vaccine deal (NYSE:PFE)
Pfizer COVID pill effective on Omicron; not linked to disease rebound – FDA (NYSE:PFE)
Pfizer deal to acquire Seagen sends cancer drug maker's shares 18% higher (NYSE:PFE)
Biosimilars expected to save $180B over next five years as more gain approval (NYSE:PFE)
Pfizer, GSK gearing up for RSV vaccine rollouts this year (NYSE:PFE)
U.K. announces spring COVID booster program for at-risk individuals (NYSE:PFE)
Biden to announce plan to keep Medicare solvent beyond 2050 (NYSE:PFE)
Flu and COVID combo shots unlikely this year, FDA’s top vaccine official says (NYSE:PFE)
FBI Director says novel coronavirus likely originated from China lab leak (NYSE:PFE)
$AIM Try to name another bio stock in trials with $BMY $MRK $AZN and PFE.
Hot Stocks: SGEN climbs on takeover interest; PFE sets 52-week low; TGNA drops; KOS rises
Pharma companies dominate list of innovation leaders thanks to patents (NYSE:PFE)
Pfizer(PFE): Says Pipeline Of Drugs Will Ease Transition From COVID.
Pfizer to face FDA AdCom meeting for full approval of COVID-19 pill (NYSE:PFE)
Completed head and shoulders on PFE? Time to short?
Pfizer, BioNTech start trial for first mRNA-based shingles vaccine (NYSE:PFE)
Medicare mulls rebates in 2025 for drug prices rising faster than inflation (NYSE:PFE)
Pfizer/BioNTech, EU in talks to cut COVID vaccine deliveries for higher prices (NYSE:PFE)
PFE stock falls as Pfizer downgraded at UBS on COVID worries (NYSE:PFE)
Omicron boosters protect against new COVID strains up to three months - CDC (NYSE:PFE)
FDA plans an annual schedule for updated COVID shots (NYSE:PFE)
2023-01-16 Wrinkle-brain Plays (Mathematically derived options plays)
2023-01-16 Wrinkle-brain Plays (Mathematically derived options plays) DD
Pfizer, AbbVie, GSK, Eli Lilly among drugmakers to raise prices (NYSE:PFE)
Thoughts on shorting MRNA and PFE
Mentions
Poor PFE, MRNA etc....this is what happens when you appoint a conspiracy theorist as your health secretary.
so much fud for PFE. neverending. I think this stock retests the 20.92 low and goes below 20. we gonna see an 8.5% dividend on this soon.
I’m starting to think my undying faith that I will get back to break even on PFE and BMY will never happen. Just seems like pharma is a terrible place to be and these two names are the worst in the sector. As soon as I think a bottom is set in and they are starting by to build momentum…straight back down. The likelihood of both of these being sub-$50b market cap companies seems pretty much a certain now.
I have no skin in the game, I lost all my money to PFE a pos stock. But bears please realize that you can’t stop the pump.
I am going to against my better instincts and make an attempt at a value investment. I have bought PFE. I am declaring power botton. We will see how this goes....
By no means is everything at its peak. Check out BMY and PFE (big drug stocks) . And most oil and refining companies. I agree that a lot of "non-growth" stocks are priced with growth-level P/E's so I think you may easily see some dramatically lower re-valuation of some of them, but I have no idea how to predict when the market will notice that a particular stock "has no clothes!"
UNH, GOOGL shares finally paying of. hoping PFE joints the boat next.
I believe the hearing is tomorrow on vaccines? I loaded up on puts on MRNA< PFE and NVAX
PFE Puts are going to print if they get charged with crimes against humanity.
Still no one else with PFE Puts?
I am holding the stocks I’m in love with (ASTS, RKLB, PANW) for the long haul. I’ve shifted some money into high dividend stocks including PFE and VZ. VZ is like a utility at this point.
Depends on a lot of factors. I just bought a decent position in UPS on a mean reversion + high div bet. I have VIG, VYMI, DGRO and will be adding PFE and other individual beat down high div stocks soon
they're actually getting rid of the vaccine requirements in Florida huh. highly regarded move. puts on PFE and MRNA. calls on dumbass parents and polio?
Put/Call ratio is .51 so it's a cheap bet to make with big pay off since everyone seems to think PFE is trustworthy but if it materializes it's probably going to tank the stock. Not saying I'm right, but risk/reward ratio looks good to me and those are the options I like to buy.
Is anyone else playing PFE Puts? If news comes out that they hid a whole lot of negative data about the efficacy of the vaccines they're probably going to tank.
Makes me glad I dumped PFE stock a few weeks back.
I pulled out 50% of my portfolio this year (actually more, but I've been reinvesting in what I consider to be undervalued, long term growth companies). Despite missing out on some significant gains, I am extremely concerned about current market movement and will not be investing in tech for a while. I do expect the bubble to pop, and I rather miss out on some gains than take heavy losses. Top holdings are PFE (dividend and what I consider to be a great long term company making all the right moves) and BRK.B. GOOG is the only big tech company I think is reasonably valued. But I think there will be a major correction in the next year so I'm going to hold off for a while. That's just me. I know I can't time the market, but I can wait until I find value to invest.
Don’t buy PFE short to 0
Fake news, I have PFE and I'm a poor (now)
Buy PFE, it's more consistent Down one day, and down more the next
Well you are going to sacrifice your capital for a 7% dividend. If you put your money in a year ago, that 30K would be worth about 25,800. Since the 7% yield is yearly, that's about 1.75% per quarter. So do keep it simple, just say we took the yield keeping it as 30K the whole time, since I don't feel like doing math lol, you are getting 510 per quarter from that 30K. So you'd still be down even with adding in the dividend and depending on what account you hold your money in, that would also be taxable, which would actually lower the real amount you get. If you just put in the SPY, you'd be up 15%. Unless you have a compelling reason to invest in PFE, just seems like I'd rather have the money go into a low cost index fund.
Didn't RFK just first the CDC head because she was pro Covid vax? How much of PFE's value is tied to the Covid vaccine? If that's already priced in then sure but RFK seems to hate pharma and this admin takes a lot of action.
someone convince me to not dump like 30k in PFE. fairly stable dividend at 7% (wow), stock price keeps staying depressed despite consistent updated guidance etc.
Adding something like a PFE, NKE, CAKE, or UNH would help round you out and get you a little bit more dividends coming in
FDA Authorizes Covid Vaccines For Those At Higher Risk – per RFK Jr -Shares of $PFE $MRNA $NVAX $BNTX spiked higher at 12:35 on the news (& surrendered the gains w/in 6 minutes) - Moderna had notched multi-year year lows this week on news that to Ban COVID-19 Vaccine ‘Within Months'
MRNA and PFE.. damn, just brutal
I bought PFE at like 51 dollars. I lost all my money to that piece of shit stock
PFE not making a move for VKTX is why they are such a loser. Nobody wants cobid vaccine
RIP PFE and BNTX https://www.benzinga.com/markets/large-cap/25/08/47316871/trump-administration-plans-to-pull-covid-19-vaccines-off-market-within-months
research the team. their entire career is a long list of BOs, especially CEO and chairman. listen to any call. CEO explicitly states that the goal is and will always be BO. call right after approval said that the offer was not "acceptable to the board". $PFE has a 15% stake so i'm still leaning toward them. also means they have BP backer.
In terms of biotech and pharma in general the space is more risky that normal with all the layoffs and FDA changes. I have been watching SRPT and PFE a lot lately. Both not necesarily small caps but extremely undervalued in my opinion, especially SRPT.
Had 250 PFE $40 January 21 2021 calls I sold for a $45,000 profit. Felt like it was the best thing in the world, and my first big win. Had I held for just a month or so longer when PFE hit $60 I would’ve made like $500,000 That was my similar “ETH” experience that still pains me
PFE is definitely on the patent treadmill, but that’s what big pharma does. They take other people’s inventions and distribute them widely. I’m not sure what a breakup would do, but I don’t think you get that pharma r&d isn’t a good investment. Martin Shkrelli is a dirtbag for raising prices on generics, but he’s not wrong about slashing r&d.
I get your point about the market broadening, but there are some things in this set of names that I wouldn't own in general. PFE is a stagnant company that buys growth (often overpaying) rather than innovates - it often reminds me of Immelt-era GE and it desperately needs its own version of Larry Culp. AGNC is "yield chasing" imo - over time it will not outgrow that yield and will just continue to erode. JMIA is eh - "the next (fill in the blank)" or the "fill in the blank (amazon, etc) of x" often (not always but often) ultimately don't work. The energy stuff isn't bad, but choosing to hold it for lasting periods where it's out of favor is opportunity cost. I am now looking more at these sorts of names but as a place to re-deploy after selling things that have been in favor. "Don't sell your losers at this moment !" I think there is something to letting one's winner's run, but if something is a persistent loser over a reasonable period of time, there has to be some reflection as to whether or not it has lasting issues. IMO, one should also take into consideration how much they allocate to out of favor stuff and how long they are willing to tolerate it being out of favor; optimally you're primarily in in favor stuff for long periods of time and then opportunistically (not the entire portfolio, to some degree) look at the bargain bin after stuff has been sitting in it for a while.
I do agree with you. In fact, that's why I bought NVO near what appears might be its bottom, and why I have been fine with letting my PFE drip since I bought it (only stock I own that i can say that about), and why I haven't been freaking out about my energy stocks or even UNH.
I feel like that 40% drop might level the playing field on potential negotiations. PFE has been trending up too. The data wasn’t bad at all. It seemed like a crazy overreaction to another typical glp1 drug having the usual reactions all the other drugs do. Placebo had 13% drop out rate. Was the market expecting the first drug ever created that didn’t have side effects? I bought that dip and have a sneaking feeling you probably do.
PFE at a key resistance level, puts?
Time to move away from IA stocks and invest in great robust old business stocks such as NESN, PFE and MRK!
Time to move away from IA stocks and invest in great robust old business stocks such as NESN, PFE and MRK!
$PFE approved to begin clinical trials of new monkeynucleosis drug
It's very likely a lot of potential buyers such as PFE/LLY/NVO were waiting for the oral data. Now that they have it and they know it's great, it's very possible there will be discussions and possibly an acquisition/partnership soon. Maybe before EoY? I don't know. Without M&A leaks, I expect the share price to remain between $25 and $35.
KHC, PFE, IBM etc...the blues are holding it together...this might be time to start nibblin' on some undervalued beaten down blue's...like seriously...some of these have been just smoked the past 2 years, paying over 6% dividend (savings account pays next to 0)...not too sure how you could go wrong on some of these.
Agreed. Data was not 100% blowout so its a sell the news event. Fact is, VKTX remains the only direct competitor to LLY because the molecule is nearly identical with the same MOA. LLY will be announcing their oral Tirzepetide product soon I bet, this will further validate VKTX as a solid play. Will it be the best product on the market? maybe, maybe not. Will it be top 3? yes with LLY and NVO. Is it better than PFE, AMGN, MRK, Roche, etc? Yep. If those companies want to compete its the right company to partner with. Lastly, NVO's cost to mfg is huge compared to Tirzepetide, I imagine VKTX will have similar costs to LLY when all is said an done. meaning as price erodes VKTX still has an opportunity to capture a good portion of market share from NVO.
Many consider oversold? NVO and PFE. Two that are oversold and nobody’s looking at? KSPI and TLPFY.
Many consider oversold? NVO and PFE. Two that are oversold and nobody’s looking at? KSPI and TLPFY.
Hard to say. I believe they already made multiple offers, which were shut down because they were too low. The main problem is premium perception. Pfizer's CEO of course knows VKTX would be worth 20-30B in a buyout scenario, but that is a 400-700% premium over today's price. Pfizer's shareholders (who aren't necessarily data-savvy) may then be angry because they'd feel this is overpaying, but they'd be wrong. I'd say somewhere before 2028 for an accepted offer. It really depends, if Pfizer is the only one bidding, they may want to wait until P3 topline data, even if they'd pay more, at least the risk would be down a lot. But if multiple players are bidding (probably PFE+NVO and maybe Merck), Pfe will close the deal fast at a large premium because they are done if they don't do an acquisition soon.
PFE sickle cell fails but PFE is up. Interesting.
High PP you say? Puts on PFE.
Hey brother I just wanted to let you know that the market is controlled by lizard people and there's nothing you can do about it. Trust me, a few buddies and I went down into the sewers to try and find them. All we found was a bunch of diapers and a few new diseases. The sexual diseases could've likely been avoided if we didn't have sex down there but oh well - live and learn. I guess what I'm saying is thank you God for drug companies. PFE 100
PFE and INTC I follow and know them. Even if you are in losses, I do not doubt that in a few years you will see your investment with profits. They are heavily punished on the stock market and undervalued. They shouldn't go down much more and they are big companies
I would do exactly this too, but sell 25 calls until you get it- wait you have 50 shares never mind just sell. PFE at least pays a 7% dividend and has for over 25 years paid or raised it.
exit liquidity happening, all the priced in stocks like HOOD, RKLB, PLTR, GEV plunging and oversold stocks like UNH, DOW, PFE, BRKB mooning? clear rotation into value stocks to tide through the 2 months downtrend before christmas rally
At the time I thought they would be good investments. I didn't take into account the dividends so actually for NVEC and PFE because of the dividends I am ahead. For INTC even with the dividends I am still at a major loss.
PFE is a buy and hold for me. They have solid fundamentals and pay a good dividend
Personally, I would sell INTC and hold PFE. I'm not familiar with NVEC.
PFE and NVEC have really high dividends. Are you sure you aren't up on them if you factor those in? INTC is a mess.
you know what was cheap a few years ago? $META. look how that turned out, also SOFI, also PLTR a few years ago. $NVO, $LLY, $UNH, $PFE are all out of favor right now. their businesses are still embedded in the economy, they aren't going anywhere. my other favorite out of favor plays were $XOM a few years ago and $MO last year.
Oral data due imminently, fireworks to come, could see plus or minus $25. My bet is plus given the overwhelming positive data released in both SQ and oral. Remember it’s the same compound. Just a matter of time before PFE, MRK or ABBV takes them out imo.
$VKTX - Truist JOON LEE Bottom line $VKTX VK2735 takes best of both worlds from $LLY & $ NVO obesity playbooks. VK2735 takes the more effective GLP1/GIP dual agonism strategy from $LLY &takes more seamless SQ to oral maintenance strategy from NOVO. There is a lot to like heading into Ph2 VENTURE Oral topline in the fall time frame. $PFE Bourla finally has a shot at obesity and Lilly if he has the guts to do the right things
My thoughts on the so called "middlemen" of the pharma industry, that are apparently going to lose all that revenue, like its alot...UNH and the likes are not going to have a good year in my opinion, if they are the "middlemen" Those fuckers buy drugs from PFE etc...mark up the price, sell to you...they are going to get rid of that markup/middleman and go right to direct sales from the manufacturer. So whoever profits from pharmaceuticals....other than the manufacturers...they are fuked
PFE and LLY If your outlook is to hold to 2030 then I think you should invest in Pfizer. Much of the Seagen oncology pipeline matures over the next 5 years and they're paying you a great dividend (7%) to wait for it to sprout. PFE just reported a great quarter Tuesday; listen to their conference call and decide for yourself.
No, you aren't the one causing PFE to be stuck. 'Tis me, bagholding since 2023, with an average around... $34, I think, between new purchases and divvy reinvestments.
Okay, but what if you did sell PFE and BABA so the rest of us holding them could benefit? lmao but for real I feel you on this kinda shit lately. I swear anytime I sell something on mediocre/bad earnings it just continues upward.
If you intend to buy either, I beg you to look at these two charts, it’s incredibly obvious which company executes more consistently https://m.macrotrends.net/stocks/charts/PFE/pfizer/revenue https://m.macrotrends.net/stocks/charts/NVO/novo-nordisk/revenue
healthcare is at record low snetiment. PFE crushed earnings, raised guidance and basically crashed back down to pre-earnings.
lol PFE gave back all its earnings gain and some, now trading at a forward P/E of 7. Pretty ugly place to be
"Robert F. Kennedy Jr. announced in a statement Tuesday that 22 projects, totaling $500 million, to develop vaccines using mRNA technology will be halted. " My PFE only just started to go green again reeeeeeee
My plays: Uber call Snap put 2 SMCI calls AMD put 2 PFE call
As fun as it was, I fully expect PFE to give back all its earnings pop by end of month as is continues to grind toward sub-20s
PFE just made the biggest move to the upside in probably 5 years. 😂
My PFE Puts not gonna recover, should I just try to sell them now to recoup something?
Whose the guy that said he bought PFE puts yesterday? How's he doing?
200 shares PFE or 100 NVO? or is it the same thing
Hit on COIN lottos last week (240p; $70 -> $2300) and hopping on PFE and SNAP lottos this week lol
SPY 640 8/8 CALLS PFE 120 8/8 PUTS PLTR 200/130 CALL&PUTS you’re welcome
PFE puts or calls? Stock twit seems to be bullish on it
I use Morningstar ratings for this sort of thing. You need Premium, which costs, but is free at your local library. My current five and four star strong buy and buy holdings are: \*\*\*\*\* WU PFE BMY O \*\*\*\* LMT CCI ET GOOG VZ MCD Reply with any tickers you'd like me to look up and I can get you the ratings and maybe the analysis text.
Meh UNH, NVO, PFE, MRNA will all be a buy in about a month or so. UNH is just too big to fail and way oversold, NVO because the fat shoots will become part of Medicaid, PFE cuz their greed is next level and MRNA because RFK will be gone.
Pharma and healthcare in 100% un-investable going forward. They are only going lower as the market will continue to churn higher. A few projections that we will see in the next 90 days: PFE -> 15 BMY -> 30 NVO -> 38 LLY -> 600 Merck ->65 UNH -> 150 CI -. 165
Sold at $98 in 2025 here lmao kill me along with AVGO. Bought BYDDY and PFE instead 🤣🤣🤣🤣
Yep. Bought 44P on BMY, 22P on PFE. Not touching NVO, IV too high.
PFE just broke upward trending support. Next support is 22 followed by 18. BMY broke below support of 46, next support is 42. NVO heading to 45. Sheesh a lot of pain still lol
PFE down 6 straight days, buying puts 22 strike end of month. This is going to be absolutely destroyed after earnings. Pharma should see an easy 20% further contraction. Super easy money to short.
I own UNH, PFE, and ABBV so it probably makes up a good chunk of my taxable account. I'm not that worried about it though unless the U.S. moved to a Universal Healthcare System. In which case, I would gladly take the loss.
Sold my UNH at 270. Made $100 on the CSP I sold. I’m done with that stock. I’m done with health care completely. PFE and HUM fuk me last year.